Metacrine | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Mar 24, 2023 17:29 ET
Metacrine | 8-K: Current report
Mar 24, 2023 17:28 ET
Metacrine | S-8 POS: S-8 POS
Mar 23, 2023 16:34 ET
Metacrine | S-8 POS: S-8 POS
Mar 23, 2023 16:32 ET
Metacrine | 8-K: Current report
Mar 23, 2023 16:31 ET
Metacrine | 8-K: Current report
Mar 15, 2023 17:20 ET
Metacrine | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Mar 3, 2023 17:25 ET
Metacrine | 8-K: Current report
Mar 3, 2023 17:23 ET
Metacrine | DEF 14A: Definitive proxy statements
Feb 13, 2023 08:30 ET
Metacrine | 8-K: Current report
Feb 9, 2023 16:06 ET
Metacrine | 8-K: Current report
Feb 3, 2023 17:08 ET
Metacrine | 8-K: Current report
Feb 1, 2023 16:16 ET
Metacrine | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
Jan 24, 2023 17:17 ET
Metacrine | 8-K: Current report
Jan 24, 2023 17:13 ET
Metacrine | 8-K: Current report
Dec 23, 2022 16:15 ET
Metacrine | DEFA14A: Others
Dec 14, 2022 21:52 ET
Metacrine | 8-K: METACRINE REPORTS THIRD-QUARTER 2022 RESULTS
Nov 14, 2022 16:15 ET
Metacrine | DEFM14A: Definitive proxy statement relating to merger or acquisition
Nov 10, 2022 16:19 ET
Metacrine | 8-K: Current report
Oct 11, 2022 16:15 ET
Metacrine | 8-K: Current report
Sep 6, 2022 16:31 ET
No Data
No Data